Accolade, Inc. (ACCD)

NASDAQ: ACCD · Delayed Price · USD
15.89
-0.80 (-4.79%)
At close: Jan 27, 2022 4:00 PM
16.00
0.11 (0.69%)
Pre-market:Jan 28, 2022 7:12 AM EST
Market Cap1.06B
Revenue (ttm)275.50M
Net Income (ttm)-93.29M
Shares Out66.96M
EPS (ttm)-1.75
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume793,400
Open16.98
Previous Close16.69
Day's Range15.72 - 17.55
52-Week Range15.73 - 56.72
Betan/a
AnalystsStrong Buy
Price Target36.58 (+130.2%)
Earnings Daten/a

About ACCD

Accolade, Inc. develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees ...

IndustryHealth Care Technology
IPO DateJul 2, 2020
Employees2,300
Stock ExchangeNASDAQ
Ticker SymbolACCD
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 12 analysts, the average rating for Accolade stock is "Strong Buy." The 12-month stock price forecast is 36.58, which is an increase of 130.21% from the latest price.

Price Target
$36.58
(130.21% upside)
Analyst Consensus: Strong Buy

News

Accolade to Participate in the 24th Annual Needham Growth Conference

SEATTLE, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, will participate in 24th Annual Needham Growth Con...

2 weeks ago - GlobeNewsWire

Accolade surged 25% this morning: what's fuelling the stock?

Shares of Accolade Inc (NASDAQ: ACCD) opened about 25% up on Tuesday after the software and technology company reported better-than-expected financial results for its third quarter last night. Q3 result...

2 weeks ago - Invezz

Accolade Shares Trade Higher After 117% Jump In Q3 Sales

Accolade Inc (NASDAQ: ACCD) reported Q3 FY22 sales of $83.5 million, up 117% Y/Y, beating the consensus of $75.89 million. The adjusted EBITDA loss widened to $(11.9) million, and the adjusted gross mar...

2 weeks ago - Benzinga

Accolade (ACCD) Reports Q3 Loss, Tops Revenue Estimates

Accolade (ACCD) delivered earnings and revenue surprises of 18.75% and 9.85%, respectively, for the quarter ended November 2021. Do the numbers hold clues to what lies ahead for the stock?

2 weeks ago - Zacks Investment Research

Accolade Announces Results for Fiscal Third Quarter 2022

SEATTLE, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2021.

2 weeks ago - GlobeNewsWire

Earnings Preview: Accolade (ACCD) Q3 Earnings Expected to Decline

Accolade (ACCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 weeks ago - Zacks Investment Research

Accolade to Announce Fiscal Third Quarter 2022 Financial Results

SEATTLE, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal th...

1 month ago - GlobeNewsWire

Accolade to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

SEATTLE, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 400 employers and millions of members, will participate in the Piper Sandler 33rd Annual ...

1 month ago - GlobeNewsWire

Accolade expands world-class executive leadership team with marketing and customer success experts

SEATTLE, Nov. 17, 2021 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of people and their families with exceptional healthcare, announced today the expansion of its ex...

2 months ago - PRNewsWire

Accolade to Participate in the Credit Suisse 30th Annual Healthcare Conference

SEATTLE, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 400 employers and millions of members, will participate in the Credit Suisse 30th Annual ...

2 months ago - GlobeNewsWire

New Strong Sell Stocks for October 28th

ACCD, CMTL, FRO, GP, and KMB have been added to the Zacks Rank #5 (Strong Sell) List on October 28, 2021.

Other symbols:CMTLFROGPKMB
2 months ago - Zacks Investment Research

New Strong Sell Stocks for October 19th

ACCD, EAT, ILMN, MAXN, and TM have been added to the Zacks Rank #5 (Strong Sell) List on October 19, 2021

Other symbols:EATILMNMAXNTM
3 months ago - Zacks Investment Research

Accolade to Showcase Personalized Healthcare for Employers and Health Plans at HLTH Boston 2021

SEATTLE, Oct. 14, 2021 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), a healthcare provider that serves over 400 employers and millions of members, will be at HLTH Boston 2021 to engage in discussions a...

3 months ago - PRNewsWire

Accolade Brings WellRight's Corporate Wellness Programs into its partner ecosystem

SEATTLE, Oct. 12, 2021 /PRNewswire/ -- Accolade (Nasdaq: ACCD), a healthcare provider serving millions of people and their families, announced today that WellRight, the provider of the nation's most hol...

3 months ago - PRNewsWire

Accolade (ACCD) Reports Q2 Loss, Tops Revenue Estimates

Accolade (ACCD) delivered earnings and revenue surprises of 4.44% and 4.04%, respectively, for the quarter ended August 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Accolade Announces Results for Fiscal Second Quarter 2022

SEATTLE, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2021.

3 months ago - GlobeNewsWire

Insurtech Leader Announces New Employer-Paid Insurance Plan Featuring Virtual Primary Health Care, Dental Coverage an...

DALLAS, Oct. 4, 2021 /PRNewswire/ -- Insurance Applications Group, Inc. (IAG), a leading Insurtech company specializing in proprietary employee benefit products and administrative technologies for the h...

3 months ago - PRNewsWire

Earnings Preview: Accolade (ACCD) Q2 Earnings Expected to Decline

Accolade (ACCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 months ago - Zacks Investment Research

Accolade doubles down on personalized mental health services with new offerings

Health benefits platform company Accolade is expanding its offerings to add two personalized services with an emphasis on mental health, the company announced Tuesday.

4 months ago - GeekWire

Accolade introduces new healthcare category: Personalized Healthcare

SEATTLE, Sept. 21, 2021 /PRNewswire/ -- Accolade, Inc. (Nasdaq: ACCD), the company that provides millions of people and their families with exceptional healthcare, today introduced Personalized Healthca...

4 months ago - PRNewsWire

Accolade Invites Media, Investors and General Public to Opening of Evolve21

SEATTLE, Sept. 20, 2021 /PRNewswire/ -- WHAT:             Accolade, Inc. (Nasdaq: ACCD) the company that provides millions of people and their families with exceptional healthcare will be making an anno...

4 months ago - PRNewsWire

Accolade to Participate in Upcoming Investor Conferences

SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming in...

4 months ago - GlobeNewsWire

New Strong Sell Stocks for August 17th

ACCD, CHRS, ELVT, FLGT, and GSHD have been added to the Zacks Rank #5 (Strong Sell) List on August 17, 2021.

Other symbols:CHRSELVTFLGTGSHD
5 months ago - Zacks Investment Research

Accolade to Participate in the 41st Annual Canaccord Genuity Growth Conference

SEATTLE, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the 41st Annual Canaccord ...

5 months ago - GlobeNewsWire

New Strong Sell Stocks for July 12th

ACCD, CMTL, HEXO, NTRB, and GP have been added to the Zacks Rank #5 (Strong Sell) List on July 12, 2021

Other symbols:CMTLGPHEXONTRB
6 months ago - Zacks Investment Research